McCarthy Sean A. (CIK 0001654058)

Latest company ownership

Shares held
93,158
Last filed at
Nov 10, 2025
Confidence Score
33.7
2025Q4
Confidence Score History
2017Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 6, 2025 Nov 10, 2025 CytomX Therapeutics, Inc. CEO Sell 26.3 -101,793 -8.61% ✓ $461.9K
Jun 13, 2025 Jun 17, 2025 CytomX Therapeutics, Inc. CEO Sell 42.5 -55,511 -4.48% ✗ $149.3K
Mar 18, 2025 Mar 20, 2025 CytomX Therapeutics, Inc. CEO Sell 46.3 -37,656 -3.34% ✗ $22.6K
Aug 20, 2024 Aug 22, 2024 CytomX Therapeutics, Inc. CEO Sell 46.3 -13,898 -1.82% ✗ $17.1K
Mar 19, 2024 Mar 21, 2024 CytomX Therapeutics, Inc. CEO Sell 46.3 -20,223 -3.17% ✗ $42.2K
Dec 20, 2023 Dec 22, 2023 CytomX Therapeutics, Inc. CEO Sell 46.3 -13,551 -2.41% ✗ $18.7K
Sep 20, 2023 Sep 22, 2023 CytomX Therapeutics, Inc. CEO Sell 86.3 +25,399 5.09% ✗ $19K
Mar 16, 2023 Mar 20, 2023 CytomX Therapeutics, Inc. CEO Sell 46.3 -7,121 -1.46% ✗ $13.4K
Jul 19, 2022 Jul 21, 2022 CytomX Therapeutics, Inc. CEO Sell 86.3 +25,089 6.99% ✗ $21.2K
Jun 16, 2021 Jun 21, 2021 CytomX Therapeutics, Inc. CEO Sell 7.5 -100,000 -49.76% ✓ $704.5K
Mar 31, 2021 Apr 2, 2021 CytomX Therapeutics, Inc. CEO Sell 7.5 -100,000 -32.58% ✓ $749.5K
May 12, 2020 May 14, 2020 CytomX Therapeutics, Inc. CEO Sell 7.5 -36,000 -29.92% ✓ $540K
Nov 1, 2018 Nov 5, 2018 CytomX Therapeutics, Inc. CEO Sell 41.3 -6,526 -2.53% ✓ $97.9K
Sep 4, 2018 Sep 6, 2018 CytomX Therapeutics, Inc. CEO Sell 22.5 -13,052 -13.72% ✓ $285.3K
Jul 5, 2018 Jul 9, 2018 CytomX Therapeutics, Inc. CEO Sell 32.5 -4,497 -5.20% ✓ $112.7K
Jul 3, 2018 Jul 6, 2018 CytomX Therapeutics, Inc. CEO Sell 41.3 -2,028 -2.41% ✓ $50.9K
Jul 2, 2018 Jul 3, 2018 CytomX Therapeutics, Inc. CEO Sell 22.5 -13,052 -13.72% ✓ $305.7K
May 1, 2018 May 2, 2018 CytomX Therapeutics, Inc. CEO Sell 22.5 -19,578 -10.97% ✓ $519.7K
Mar 1, 2018 Mar 5, 2018 CytomX Therapeutics, Inc. CEO Sell 22.5 -19,578 -10.97% ✓ $576.1K
Jan 5, 2018 Jan 9, 2018 CytomX Therapeutics, Inc. CEO Sell 37.5 -6,526 -3.84% ✓ $163.2K
Jan 2, 2018 Jan 4, 2018 CytomX Therapeutics, Inc. CEO Sell 30.0 -13,052 -7.40% ✓ $274.6K
Nov 30, 2017 Dec 5, 2017 CytomX Therapeutics, Inc. CEO Sell 26.3 -13,942 -7.66% ✓ $295.4K
Nov 1, 2017 Nov 3, 2017 CytomX Therapeutics, Inc. CEO Sell 26.3 -14,342 -8.09% ✓ $284.8K
Oct 4, 2017 Oct 6, 2017 CytomX Therapeutics, Inc. CEO Sell 22.5 -19,120 -10.50% ✓ $461.4K
Oct 2, 2017 Oct 4, 2017 CytomX Therapeutics, Inc. CEO Sell 32.5 -9,562 -5.54% ✓ $177.6K
Sep 1, 2017 Sep 22, 2017 CytomX Therapeutics, Inc. CEO Sell 32.5 -9,930 -5.74% ✓ $172.1K
Aug 31, 2017 Sep 22, 2017 CytomX Therapeutics, Inc. CEO Sell 22.5 -18,756 -10.32% ✓ $328.3K
Sep 1, 2017 Sep 5, 2017 CytomX Therapeutics, Inc. CEO Sell 32.5 -9,930 -5.74% ✓ $172K
Aug 31, 2017 Sep 1, 2017 CytomX Therapeutics, Inc. CEO Sell 22.5 -18,756 -10.32% ✓ $328.3K
Aug 9, 2017 Aug 11, 2017 CytomX Therapeutics, Inc. CEO Sell 41.3 -4,781 -2.85% ✓ $71.7K
Jul 3, 2017 Jul 6, 2017 CytomX Therapeutics, Inc. CEO Sell 41.3 -4,781 -2.85% ✓ $74.2K
Jun 26, 2017 Jun 27, 2017 CytomX Therapeutics, Inc. CEO Buy 87.5 +4,245 2.67% ✓ $67.2K
Jun 5, 2017 Jun 6, 2017 CytomX Therapeutics, Inc. CEO Sell 55.0 -300 -0.18% ✓ $4.5K
May 1, 2017 May 2, 2017 CytomX Therapeutics, Inc. CEO Sell 41.3 -4,781 -2.89% ✓ $75.1K
Apr 3, 2017 Apr 5, 2017 CytomX Therapeutics, Inc. CEO Sell 32.5 -9,562 -5.55% ✓ $164.7K
Mar 20, 2017 Mar 21, 2017 CytomX Therapeutics, Inc. CEO Sell 26.3 -14,343 -8.19% ✓ $281.1K
Mar 3, 2017 Mar 3, 2017 CytomX Therapeutics, Inc. CEO Sell 28.8 -14,343 -8.19% ✓ $215.1K